iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company is headquartered in San Francisco, California.
| Revenue (TTM) | $825.34M |
| Gross Profit (TTM) | $589.74M |
| EBITDA | $17.70M |
| Operating Margin | 7.94% |
| Return on Equity | -9.63% |
| Return on Assets | 0.65% |
| Revenue/Share (TTM) | $25.43 |
| Book Value | $4.91 |
| Price-to-Book | 22.41 |
| Price-to-Sales (TTM) | 5.05 |
| EV/Revenue | 5.27 |
| EV/EBITDA | 162.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 20.10% |
| Shares Outstanding | $32.96M |
| Float | $30.82M |
| % Insiders | 1.17% |
| % Institutions | 110.74% |
Volatility is currently expanding
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.
iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.32 per share a year ago.
iRhythm Technologies NASDAQ: IRTC reported second-quarter revenue growth of 20.1% and raised its full-year outlook, while announcing an agreement to acquire VitalConnect to broaden its cardiac monitoring portfolio and enter additional patient-monitoring markets.
SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Bernstein Litowitz Berger & Grossmann LLP announces that the United States District Court for the Northern District of California has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC): UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA GLAZING EMPLOYERS AND GLAZIERS' UNION LOCAL #27 PENSION AND RETIREMENT FUND, on behalf of itself and all others similarly situated, Plaintiff, v. iRHYTHM TECHNOLOGIES, INC.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on IRTC and any ticker you trade — then tracks every position and per-strategy win rate.
